- $135.71bn
- $184.58bn
- $63.63bn
- 98
- 88
- 84
- 99
Pfizer Inc - Court in Denmark Upholds Two Lipitor Patents, Prevents Launch of Ra
AnnouncementPfizer Inc - Pfizer invite for Jan 22 analyst meeting
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc - Jean-Paul Valles Leaves Pfizer Board of Directors
AnnouncementPfizer Inc New Pfizer Data Helps to Identify
AnnouncementPfizer Inc - Pfizer to Return Indiplon Worldwide Rights to Neurocrine
AnnouncementPfizer Inc - Dividend Declaration
AnnouncementPfizer Inc - Repatriation
AnnouncementPfizer Inc - Governance
AnnouncementPfizer Inc - Dividend Declaration
AnnouncementPfizer Inc - Regulatory Approval - Product Approval
AnnouncementPfizer Inc - Pfizer Declares a 29-cent Third-Quarter, 2007, Dividend
AnnouncementPfizer Inc - Pfizer Board of Directors to Initiate Face-to-Face Meetings with Co
AnnouncementPfizer Inc - Pfizer Statement on Patent Office Communication
AnnouncementPfizer Inc Pfizer Receives Approval from Chinas Ministry of Commerce for Pendin
AnnouncementPfizer Inc - Research Update
AnnouncementPfizer Inc Pfizer Receives Approval From Australian Competition And Consumer Com
AnnouncementPfizer Inc - Esperion Therapeutics Completes $22.75 M Series A Financing
Announcement